LOCOREGIONAL

作品数：58被引量：357H指数：12
导出分析报告
相关领域：医药卫生更多>>
相关作者：李军王进兵高岩王辉东杨国姿更多>>
相关机构：上海交通大学医学院附属第九人民医院复旦大学附属肿瘤医院丽水市中心医院吉林大学第一医院更多>>
相关期刊：《World Journal of Gastroenterology》《Oncology and Translational Medicine》《Hepatobiliary & Pancreatic Diseases International》《Journal of Clinical and Translational Hepatology》更多>>
相关基金：国家自然科学基金广东省自然科学基金Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Precision oncology: The role of minimally-invasive ablation therapy in the management of solid organ tumors
《World Journal of Radiology》2025年第1期1-18,共18页Farbod Fazlollahi Mina S Makary 
Solid organ tumors present a significant healthcare challenge,both economically and logistically,due to their high incidence and treatment complexity.In 2023,out of the 1.9 million new cancer cases in the United State...
关键词：MINIMALLY-INVASIVE Non-invasive Solid organ tumor Ablation LOCOREGIONAL 
Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?
《Liver Research》2024年第3期141-151,共11页Walaa Abdelhamed Hend Shousha Mohamed El-Kassas 
Hepatocellular carcinoma(HCC)is the sixth most prevalent form of cancer globally and the third leading cause of cancer-related mortality.The incidence of portal vein tumor thrombosis(PVTT)in HCC patients is 21%at one ...
关键词：Hepatocellular carcinoma(HCC) Portal vein tumor thrombosis(PVTT) STAGING Systemic therapies Locoregional treatment Immunotherapy 
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma被引量：1
《Chinese Journal of Cancer Research》2024年第2期167-194,共28页Hanyuan Liu Chunmei Wang Ruiqiang Wang Hengsong Cao Yongfang Cao Tian Huang Zhengqing Lu Hua Xiao Mengcheng Hu Hanjin Wang Jun Zhao 
Hepatocellular carcinoma(HCC) is responsible for a significant number of cancer-related deaths worldwide and its incidence is increasing. Locoregional treatments, which are precision procedures guided by imaging to sp...
关键词：Locoregional therapies transarterial chemoembolization hepatocellular carcinoma IMMUNOTHERAPY tumor microenvironment 
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?
《World Journal of Hepatology》2023年第12期1284-1293,共10页Alessandra Elvevi Alice Laffusa Federica Elisei Sabrina Morzenti Luca Guerra Antonio Rovere Pietro Invernizzi Sara Massironi 
Intrahepatic cholangiocarcinoma(iCCA)is recognized as the second most frequently diagnosed liver malignancy,following closely after hepatocellular carcinoma.Its incidence has seen a global upsurge in the past several ...
关键词：Intrahepatic cholangiocarcinoma Transarterial radioembolization Locoregional treatment Overall Survival Response rates Neo-adjuvant therapy Combined Therapies Prognostic factors 
Radiological findings in non-surgical recurrent hepatocellular carcinoma:From locoregional treatments to immunotherapy被引量：2
《World Journal of Gastroenterology》2023年第11期1669-1684,共16页Davide Ippolito Cesare Maino Marco Gatti Paolo Marra Riccardo Faletti Francesco Cortese Riccardo Inchingolo Sandro Sironi 
Since hepatocellular carcinoma(HCC)represents an important cause of mortality and morbidity all over the world.Currently,it is fundamental not only to achieve a curative treatment but also to manage in the best way an...
关键词：Carcinoma HEPATOCELLULAR Liver Ablation CATHETER Radio frequency ablation Ablation techniques Medication therapy management RECIST 
Handy locoregional flaps for nasal reconstruction
《Chinese Journal of Plastic and Reconstructive Surgery》2023年第1期13-19,共7页Ahmed Hassan El-Sabbagh 
Background Skin lesions on the nose are common.Multiple surgical techniques have been used for nasal reconstruction.These options may be autogenous or alloplastic and can be performed in single or multiple stages.The ...
关键词：NOSE Skin defect Pedicled flap 
Salvage locoregional therapies for recurrent hepatocellular carcinoma被引量：1
《World Journal of Gastroenterology》2023年第3期413-424,共12页Cody R Criss Mina S Makary 
Hepatocellular carcinoma(HCC)is the second most common cause of cancerrelated death worldwide.Despite the advent of screening efforts and algorithms to stratify patients into appropriate treatment strategies,recurrenc...
关键词：Recurrent hepatocellular carcinoma Locoregional therapy Transarterial chemoembolization Transarterial embolization Transarterial radioembolization Ablation Salvage therapy 
Immunotherapy prototype Mark 3.0 model in primary liver cancer:adding locoregional stereotactic therapy and prognostic factors classification management被引量：2
《Medical Review》2022年第6期547-552,共6页Xu Yang Nan Zhang Yang Song Xiaobo Yang Xinting Sang Haitao Zhao 
supported by National High Level Hospital Clinical Research Funding[2022-PUMCH-B-128],CAMS Innovation Fund for Medical Sciences(CIFMS)[2022-I2M-C&T-A-003][2021-I2M-1-061][2021-I2M-1-003];CSCO-hengrui Cancer Research Fund[Y-HR2019-0239][Y-HR2020MS-0415][Y-HR2020QN-0414];CSCO-MSD Cancer Research Fund[Y-MSDZD2021-0213]and National Ten-Thousand Talent Program.
Immune checkpoint inhibitors(ICIs)like programmed cell death-1(PD-1)/programmed death-ligand 1(PD-L1)inhibitor have shown considerable efficacy in several important cancers including primary liver cancer(PLC)like hepa...
关键词：hepatocellular carcinoma immune checkpoint inhibitors primary liver cancer prognostic factors programmed cell death-1 stereotactic therapy 
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
《World Journal of Gastroenterology》2022年第34期4929-4942,共14页Carlo Sposito Davide Citterio Matteo Virdis Carlo Battiston Michele Droz Dit Busset Maria Flores Vincenzo Mazzaferro 
Despite stringent selection criteria,hepatocellular carcinoma recurrence after liver transplantation(LT)still occurs in up to 20%of cases,mostly within the first 2–3 years.No adjuvant treatments to prevent such an oc...
关键词：Liver transplantation Hepatocellular carcinoma IMMUNOSUPPRESSION RECURRENCE Surgical treatment Locoregional treatment Systemic treatment 
Combination approaches in hepatocellular carcinoma:How systemic treatment can benefit candidates to locoregional modalities被引量：1
《World Journal of Gastroenterology》2022年第28期3573-3585,共13页Leonardo Gomes da Fonseca Raphael L C Araujo 
The management of hepatocellular carcinoma(HCC)is challenging because most patients have underlying cirrhosis,and the treatment provides,historically,a limited impact on the natural history of patients with advanced-s...
关键词：Liver cancer Hepatocellular carcinoma Immunotherapy Systemic therapy Ablation EMBOLIZATION 
全选清除导出
共6页<123456>
检索报告 对象比较 聚类工具 使用帮助 返回顶部